Document is current
Any future updates will be listed below
-
Authors
Furrer, Daniela
Kröger, Edeltraut http://orcid.org/0000-0002-5653-3979
Marcotte, Martine
Jauvin, Nathalie
Bélanger, Richard
Ware, Mark
Foldes-Busque, Guillaume
Aubin, Michèle
Pluye, Pierre
Dionne, Clermont E.
-
Funding
Funding for this research was provided by:
VITAM
Réseau québécois de recherche sur le vieillissement-FRQS
Centre de recherche sur le vieillissement de Québec, Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
- License Information
-
More Information
Article History
Received: 8 January 2021
Accepted: 10 August 2021
First Online: 4 September 2021
Declarations
:
: Not applicable.
: Not applicable.
: Edeltraut Kröger, Daniela Furrer, Martine Marcotte, Nathalie Jauvin, Richard Bélanger, Guillaume Foldes-Busque, Michèle Aubin, Pierre Pluye and Clermont E. Dionne declare that they have no conflict of interest relevant to the content of this study. Mark Ware took a leave of absence from McGill University in 2018, well after most of this review was performed, and is now the Chief Medical Officer at Canopy Growth, Canada. We want to stress that at no time Dr. Ware’s new affiliation influenced any step of this scoping review. Having been critically involved in research and in raising interest in the knowledge gap and growing request of patients to use cannabis for the treatment of chronic pain, he continues to be a collaborator in this research. Daniela Furrer has started to work at the Quebec Ministry of Health in July 2019.
